The raised guidance and strong operational metrics (44% Adj. EBITDA growth, 2.15x leverage) outweigh the minor EPS miss. Traders should watch for continued margin expansion and debt reduction; the stock may re-rate higher given the 96% analyst bullish consensus and strong historical T+20 performance (+7.93% avg).
Price Chart
Executive Summary
BrightSpring Health Services reported Q2 2026 revenue of $3,873M (+23% YoY) and GAAP diluted EPS from continuing ops of $0.39, a -2.1% miss vs consensus of $0.40. However, the company raised full-year 2026 revenue guidance to $15.1B-$15.425B and Adjusted EBITDA guidance to $820M-$845M, signaling strong operational momentum. The EPS miss is minor and overshadowed by the guidance raise, robust 44% Adjusted EBITDA growth, and a $300M debt paydown that reduced leverage to 2.15x, making this a net positive event for the stock.
Key Financial Metrics
Key Facts
- Q2 2026 revenue $3,873M (+23.0% YoY), above consensus of $3.66B
- GAAP diluted EPS from continuing ops $0.39, -2.1% vs consensus $0.40
- Adjusted EBITDA $206M (+44.2% YoY), with full-year guidance raised to $820M-$845M
- Full-year 2026 revenue guidance raised to $15.1B-$15.425B (17-19.5% growth)
- Leverage reduced to 2.15x from 2.27x QoQ, aided by $300M debt paydown
- Gross profit $493M (+31.5% YoY); gross margin improved to 12.7% from 11.9%
- Operating cash flow $43.9M in Q2; FCF not explicitly stated
- Pharmacy Solutions revenue +22% YoY; Provider Services revenue +30% YoY
- Completed secondary offering by KKR affiliates and $60M share repurchase in June 2026
Financial Impact
Revenue beat consensus by ~5.8% ($3,873M vs $3.66B); Adjusted EBITDA guidance raised by ~$25M at midpoint; $300M debt paydown reduces annual interest expense by ~$12M at ~4% rate
Risk Factors
- EPS miss vs consensus could trigger short-term profit-taking
- Dependence on government reimbursement (Medicare/Medicaid) exposes to policy risk
- Integration of Amedisys/LHC branches ($35M Adj. EBITDA contribution) carries execution risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3336665 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 8w ago | Institutional Cluster | $60.60 $61.43 | ▲ +1.37% | ▲ +0.77% | $60.25 (−0.58%) |
Jul 31, 2026 9w ago | 8-K | $59.71 $59.13 | ▼ −0.97% | ▼ −3.96% | $60.25 (+0.90%) |
Jul 31, 2026 9w ago | Press Release | $59.71 $59.13 | ▼ −0.97% | ▼ −3.96% | $60.25 (+0.90%) |
Jul 8, 2026 12w ago | Press Release | $71.58 $60.60 | ▼ −15.34% | ▼ −17.58% | $60.25 (−15.83%) |
Jun 11, 2026 16w ago | Institutional Cluster | $63.08 $71.58 | ▲ +13.47% | ▲ +11.58% | $60.25 (−4.49%) |
Jun 5, 2026 16w ago | Insider Cluster | $59.22 $70.56 | ▼ −19.15% | ▼ −17.52% | $60.25 (−1.74%) |
Jun 5, 2026 16w ago | Insider Cluster | $59.22 $70.56 | ▲ +19.15% | ▲ +17.52% | $60.25 (+1.74%) |
Jun 5, 2026 16w ago | Insider Cluster | $59.22 $70.56 | ▼ −19.15% | ▼ −17.52% | $60.25 (−1.74%) |
Jun 4, 2026 17w ago | Press Release | $57.40 $69.03 | ▲ +20.26% | ▲ +21.63% | $60.25 (+4.97%) |
May 1, 2026 22w ago | Press Release | $52.58 $59.98 | ▲ +14.07% | ▲ +8.79% | $60.25 (+14.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access